Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Approves TRIBENZOR

July 27, 2010 7:41 am | News | Comments

Daiichi Sankyo, Inc. announced that the U.S. Food and Drug Administration approved TRIBENZOR, a new three-in-one combination product taken once-daily for the treatment of hypertension.

TOPICS:

Cempra Completes Trial of Potent Antibiotic

July 27, 2010 7:32 am | News | Comments

Cempra Pharmaceuticals announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies.

TOPICS:

Study Investigates Importance of Fresh Blood

July 27, 2010 7:16 am | by Lauren Neergaard | News | Comments

Facing surgery? You could receive blood that's been stored for a week, or three weeks, or nearly six - and there's growing concern that people who get the older blood might not fare as well.

TOPICS:
Advertisement

Graphene Sheet Electrically Sequences DNA

July 27, 2010 7:11 am | News | Comments

Researchers at the University of Pennsylvania have developed a new, carbon-based nanoscale platform to electrically detect single DNA molecules.

TOPICS:

Monash Researchers Turn Fat Into Stem Cells

July 27, 2010 7:05 am | News | Comments

Australian scientists from the Monash Institute of Medical Research have reprogrammed adult mouse fat cells and neural cells to become stem cells that can differentiate into a variety of different cells, pluripotency.

TOPICS:

VARI Partners to Develop Phase 1 Cancer Program

July 27, 2010 6:57 am | News | Comments

Cancer patients in West Michigan will soon have the opportunity to access new drugs being developed to fight their disease due to a partnership being formed in Grand Rapids.

TOPICS:

Onyx Says Carfilzomib Results Promising

July 27, 2010 6:52 am | News | Comments

Onyx Pharmaceuticals Inc. reported positive clinical trial results for its cancer drug candidate, saying it worked for some multiple myeloma patients who have seen other therapies fail.

TOPICS:

Compound Decreases Metabolic Problems From Obesity

July 27, 2010 6:45 am | News | Comments

An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health. A report of the study, which was conducted with obese mice, appears online in the Journal of Clinical Investigation.

TOPICS:
Advertisement

Merck Partnering With Sinopharm On Vax

July 27, 2010 6:33 am | News | Comments

Merck & Co. said it will team up with Sinopharm, a huge Chinese distributor and maker of pharmaceutical and other health products, to market vaccines and potentially other drugs.

TOPICS:

Portable Temperature Control

July 26, 2010 8:05 am | Product Releases | Comments

The TG40 System from Centeo Biosciences Ltd. enables rapid screening of experimental temperature conditions from 4ºC to 60ºC and portable temperature control maintains set temperature during analysis.

TOPICS:

Sequencing Kit

July 26, 2010 8:00 am | Product Releases | Comments

Illumina, Inc. has launched the TruSeq SBS Sequencing kit, which will enable high-quality paired end reads of 150 base pairs, increase the output of high-quality base calls, and enhance throughput to greater than 95 Gigabases per run on Illumina's Genome Analyzer sequencing system.

TOPICS:

Thermo Establishing Tokyo Biomarker Research Center

July 26, 2010 7:50 am | News | Comments

The collaboration between Thermo Fisher's Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and the Tokyo Medical University Hospital means to establish and support a new Biomarker Research Center in Tokyo, Japan to focus on biomarker discovery and quantification.

TOPICS:

FTC Accuses Watson of Obstructing Investigation

July 26, 2010 7:44 am | News | Comments

The Federal Trade Commission has accused Watson Pharmaceuticals Inc. of delaying an investigation into a potential "pay-for-delay" deal on a generic sleep disorder drug.

TOPICS:

Many Genetic Variations Responsible for HTG

July 26, 2010 7:36 am | News | Comments

It can make blood look like cream of tomato soup. Patients with high levels of triglycerides in their blood, a disease called hypertriglyceridemia face an increased risk for heart disease and stroke.

TOPICS:

Key Enzyme Reverses Sun Damage

July 26, 2010 7:26 am | News | Comments

For the first time, researchers have witnessed how the enzyme photolyase works at the atomic level to repair sun-damaged DNA.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading